There’s less off the attention-deficit disorder drug Adderall available to the public than there used to be: some even call it a shortage. The company blames the FDA, which has limited the total amount of the drug manufactured: it is, after all, an amphetamine and a controlled substance. Manufacturer Shire has responded to these limits by… hiking the price and making fewer discounts available to consumers.

The two companies licensed to manufacture generic Adderall sued Shire last year, claiming that they weren’t able to get enough of the active ingredient to manufacture their version of the drug.

Meanwhile, the shortage has been good to Shire: bnet’s Jim Edwards calculates that the company’s revenues from Adderall are up 83%.

Faced With a “Shortage” of Adderall, Maker Jacks Up the Price — and Doubles Sales [bnet]
Adderall Shortage Has Many Worried [Fox Houston]
Pharmacies getting creative to fill the demand for Adderall in the Lowcountry [WCBD]
SHIRE PLC [SEC]

Want more consumer news? Visit our parent organization, Consumer Reports, for the latest on scams, recalls, and other consumer issues.